Clinical trial
Longitudinal Effects of Denosumab on Trabecular Bone Score and Femur Strength Index
NCT02435147 is registered in ClinicalTrials.gov with HealthEast Care System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Longitudinal Effects of Denosumab on Trabecular Bone Score and Femur Strength Index
- Lead sponsor
- HealthEast Care System
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2015
- Completion date
- June 30, 2016
- Enrollment
- 86 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bone fracture, osteoporosis